P18 Pemigatinib for previously treated locally advanced or metastatic cholangiocarcinoma: final results from FIGHT-202
Abstracts | September 20, 2022 | Volume: No volume available | Issue: No issue available | Pages: A44.1-A44
10.1136/gutjnl-2022-basl.69